Portfolio-Company Profitability Diagnostics for Private Equity
A portfolio-company profitability diagnostic rebuilds the P&L at customer, product and channel level so you can see where EBITDA is genuinely made and lost, not where the general ledger says it is. Done well, it takes weeks rather than quarters: a time-driven cost-to-serve engine plus a whale-curve view surfaces the hidden margin already inside the business, and converts it into a defensible bridge with named owners and dated quarters. That is the fastest, lowest-risk value-creation lever most operating partners are not yet pulling.
The 100-day profitability baseline
The value-creation clock starts at close. McKinsey's work on private-capital value creation finds that the earliest phase of ownership carries a disproportionate share of the eventual gain, which is why operating partners fight so hard to front-load the plan. Yet the analytical foundation for margin work, a customer- and product-level P&L, is usually the piece that arrives last, if at all. Teams spend the first hundred days on revenue theses and headcount while the single richest source of near-term EBITDA, the profit the company already earns and then gives away, stays invisible.
A profitability baseline fixes that in the diagnostic window. The goal is not a perfect cost model but a decision-grade one: a defensible net-margin figure for every customer, product, and channel, built fast enough to shape the value-creation plan rather than audit it after the fact. Because TDABC needs only two inputs per activity, the unit cost of supplying capacity and the time each transaction consumes, a competent team can stand up a first model on existing ERP and payroll extracts in a matter of weeks. That speed is the point: a diagnostic that lands in month one reshapes pricing and service decisions for the whole hold period, while one that lands in month nine mostly explains history.
This is where a rigorous baseline pays for itself twice, first by sizing the prize and again by de-risking it. Speed without rigour produces a number no one trusts in a board pack; rigour without speed misses the window. The discipline is to compress the timeline without hollowing out the method, and that is exactly what a purpose-built costing engine such as CostCtrl is designed to do.
Where EBITDA is really made and lost
Rank every customer from most to least profitable on a fully-loaded net margin, plot cumulative profit, and a striking shape appears: cumulative profit climbs steeply, peaks well above 100% of reported net profit, then slides back down as the loss-making tail drags it to the final figure. Practitioners call it the whale curve because the profile resembles a whale surfacing. As Baker Tilly and others document, the pattern is remarkably consistent: a top tier of accounts typically contributes between 150% and 300% of net profit, a broad middle roughly breaks even, and a bottom tier can destroy 50% to 67% of the peak before you reach the bottom line.
The reason this stays hidden is that reported margins are blended. Average gross margin looks healthy, so no one interrogates the distribution behind it. Multidimensional analysis breaks the blend apart. The same revenue can be sliced by customer, by product family, by channel, by region, and by order size at once, and the loss-makers rarely line up on a single axis. A profitable product sold through an expensive-to-serve channel to a small, high-touch account is a common way to lose money while every headline metric stays green. Reading the curve across several dimensions, rather than the classic single-axis 80/20, is what separates a diagnostic from a spreadsheet.
For the operating partner the whale curve is a map of the value at stake. The peak-to-final gap is the recoverable prize, and it sizes the margin opportunity before a single lever is pulled. The related product-mix optimization lens then asks a complementary question: given the true margins, what should the company sell more and less of?
Cost-to-serve by customer and channel
The engine underneath the curve is cost-to-serve, and the method that makes it fast and defensible is time-driven activity-based costing. Robert Kaplan and Steven Anderson's TDABC assigns the real cost of the work a company does, order handling, picking, delivery, returns, credit control, field visits, support calls, to the customers and products that actually consume it. You estimate a capacity cost rate for each resource pool (its annual cost divided by its practical capacity) and a time equation for each activity, then let the transaction data do the allocation. Kaplan and Anderson recommend setting practical capacity at roughly 80% to 85% of theoretical, leaving realistic room for breaks, changeovers and downtime, so that idle and used capacity are visible rather than smeared across output.
That last point matters commercially. Traditional allocation buries unused capacity inside product cost, making healthy products look expensive and hiding the true cost of service intensity. TDABC separates the cost of the work done from the cost of capacity sitting idle, which is precisely the distinction a buyer needs to price and to right-size. The worked example below shows how two customers with identical revenue and gross margin diverge once cost-to-serve is loaded.
| Line (annual) | Customer A · steady, palletised | Customer B · small, high-touch |
|---|---|---|
| Revenue | €480,000 | €480,000 |
| Gross margin (product only) | €144,000 (30%) | €144,000 (30%) |
| Orders per year | 52 | 1,040 |
| Order handling & picking | €9,000 | €58,000 |
| Delivery (drops, less-than-truckload) | €14,000 | €61,000 |
| Field sales & support time | €6,000 | €34,000 |
| Returns, credits & disputes | €3,000 | €27,000 |
| Total cost-to-serve | €32,000 | €180,000 |
| Net margin | €112,000 (23.3%) | −€36,000 (−7.5%) |
Same revenue, same gross margin, opposite economics. Customer B is not a bad customer, it is a mispriced and mis-served one: it needs a minimum order size, a delivery surcharge or a channel shift, not a fire sale. Multiply that logic across the book and you have the raw material for the bridge. The cost-to-serve and activity-based management disciplines describe how to turn these figures into standing operating rules rather than one-off adjustments.
Quick wins and a defensible margin bridge
A diagnostic that stops at insight is a cost, not an investment. The deliverable that matters to a value-creation team is a margin bridge: every lever gets a line, a quantified EBITDA impact, a named owner, and the quarter it is expected to land. Bain and McKinsey both describe the EBITDA bridge as the spine of the value-creation plan for exactly this reason, it converts analysis into an accountable delivery schedule the board can track. The diagnostic supplies the evidence base that makes each line defensible under scrutiny at the next exit.
The levers themselves cluster into a small number of moves, ordered here by speed and reversibility.
| Lever | What the diagnostic shows | Typical time to EBITDA |
|---|---|---|
| Surgical repricing | Accounts and SKUs priced below true net cost | 1-2 quarters |
| Service re-tiering | High cost-to-serve on low-margin, low-volume accounts | 1-2 quarters |
| Minimum order & delivery rules | Tail orders that cost more to fulfil than they earn | 1-3 quarters |
| Discount & rebate cleanup | Margin leaking through misaligned terms | 1-2 quarters |
| Mix & tail rationalisation | SKUs and customers below the cost of complexity | 2-4 quarters |
The first three lines are largely pricing and policy, they need no capital and little disruption, which is why they belong in the 100-day plan. The whale-curve peak-to-final gap sizes the total prize; the bridge phases the capture. Because the underlying model is auditable, the bridge survives challenge from a CFO, a lender, or a future buyer's diligence team, which is the difference between a margin story and a margin fact.
Common mistakes and pitfalls
The failure modes in portfolio profitability work are predictable, and nearly all of them trade rigour for the appearance of it.
Averaging the truth away. Allocating overhead as a flat percentage of revenue or headcount reproduces the blended margin and destroys the very signal you are looking for. If the method cannot make a large account look unprofitable, it cannot find the prize.
Chasing false precision. The opposite error is spending three months building a model with hundreds of drivers to answer questions that a dozen well-chosen activities would settle. In a diagnostic, decision-grade beats audit-grade. Refine after the levers are chosen, not before.
Ignoring practical capacity. Costing at theoretical capacity hides the cost of idle resources and overstates unit costs, which corrupts every downstream pricing decision. Set capacity honestly at 80% to 85% and let unused capacity show.
Confusing gross margin with contribution. A customer can carry a strong product margin and still destroy value once cost-to-serve is loaded. Any diagnostic that stops at gross margin has stopped one level too early.
Cutting the tail blindly. Unprofitable accounts are usually mispriced or mis-served, not worthless. Firing them without first testing repricing, minimum orders, or a channel shift can strip contribution that was covering fixed cost and shrink EBITDA in the wrong direction.
Leaving no owner. Findings without a bridge, and a bridge without named owners and dated quarters, quietly decay into a slide nobody executes. The management team, not the diagnostic team, has to own the lines.
A rapid, rigorous partner for the diagnostic window
Cost and Profitability runs this as a Profitability Health Check: a fixed-scope diagnostic that rebuilds the portfolio company's P&L across customer, product, channel and region, reads the whale curve, and hands the value-creation team a quantified, owned margin bridge inside the diagnostic window. The method is TDABC done properly; the engine is CostCtrl, which industrialises the modelling so the timeline is measured in weeks and the model stays live for the whole hold period rather than dying as a static spreadsheet.
We are deliberately tool-agnostic on everything around that engine. We work from whatever the company already has, ERP, POS, payroll and logistics extracts, and we hand the operating partner an auditable model their own finance team can run, not a black box that leaves with the consultants. The related profitability KPIs and performance measurement framework then keeps the recaptured margin visible on the board dashboard, so the gains show up in the next quarter's numbers and hold to exit.
The commercial case is unusually clean. The return does not depend on winning new revenue; it comes from recovering profit the business already makes and currently gives away. That is why a rapid diagnostic is often the highest-ROI, lowest-risk move available in the first hundred days.
Frequently asked questions
- How long does a portfolio-company profitability diagnostic take?
- For a mid-market company with usable ERP data, a decision-grade diagnostic runs in weeks, not quarters. TDABC needs only two inputs per activity, a capacity cost rate and a time equation, so a first model on customer- and product-level net margin can be stood up inside the diagnostic window and refined as levers are chosen. The point is to land the baseline early enough to shape the 100-day plan.
- What is cost-to-serve analysis, and why does it matter in private equity?
- Cost-to-serve assigns the real cost of serving each customer and channel, order handling, delivery, returns, support and credit, on top of product cost, to reach a true net margin. It matters because gross margin alone routinely misclassifies accounts: a customer with strong product margin can be deeply unprofitable once high-touch service is loaded. For PE, it converts blended margin into an account-level map of where EBITDA is made and lost.
- How much hidden margin does a diagnostic typically surface?
- The whale curve sizes it. Because a top tier of customers commonly contributes 150% to 300% of net profit while a loss-making tail destroys 50% to 67% of the peak, the recoverable gap between peak cumulative profit and reported profit is often substantial. The realistic near-term capture depends on pricing power and switching costs, but the diagnostic quantifies the prize before any lever is pulled rather than promising a generic percentage.
- How is this different from a quality-of-earnings review?
- A quality-of-earnings review validates the EBITDA number for the deal; a profitability diagnostic decomposes that EBITDA to find where it is created and destroyed so you can act. QoE looks backward for assurance, the diagnostic looks forward for levers. They are complementary: QoE tells you the number is real, the diagnostic tells you how to grow it.
- Does this work if the portfolio company has messy or incomplete data?
- Yes, within reason. TDABC is designed to run on the transaction and cost data a company already keeps, and a decision-grade diagnostic tolerates reasonable estimates on activity times where records are thin. Perfect data is not the entry condition; a defensible, auditable model is the output. Data gaps become an explicit part of the plan rather than a reason to wait a quarter.
Sources & further reading: Robert S. Kaplan & Steven R. Anderson, Time-Driven Activity-Based Costing (Harvard Business Review Press) · McKinsey & Company, Bridging private equity's value creation gap · Bain & Company, Private Equity Portfolio Value Creation · Baker Tilly, Visualizing customer profitability with the whale curve